A detailed history of Clark Capital Management Group, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Clark Capital Management Group, Inc. holds 4,155 shares of BSX stock, worth $346,402. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,155
Previous 4,103 1.27%
Holding current value
$346,402
Previous $281,000 13.52%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $3,501 - $4,040
52 Added 1.27%
4,155 $319,000
Q1 2024

May 15, 2024

BUY
$57.6 - $68.62 $236,332 - $281,547
4,103 New
4,103 $281,000
Q1 2020

May 15, 2020

SELL
$25.83 - $45.71 $135,684 - $240,114
-5,253 Closed
0 $0
Q4 2019

Jan 27, 2020

SELL
$37.87 - $45.37 $6,475 - $7,758
-171 Reduced 3.15%
5,253 $238,000
Q3 2019

Nov 06, 2019

BUY
$40.31 - $43.45 $218,641 - $235,672
5,424 New
5,424 $221,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $119B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Clark Capital Management Group, Inc. Portfolio

Follow Clark Capital Management Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Capital Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Clark Capital Management Group, Inc. with notifications on news.